Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ocugen, Inc. - Common Stock
(NQ:
OCGN
)
1.490
-0.180 (-10.78%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocugen, Inc. - Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
35
36
Next >
Guess? Posts Upbeat Earnings, Joins Lufax, Nortech Systems And Other Big Stocks Moving Higher On Thursday
↗
March 21, 2024
U.S. stocks were higher, with the Dow Jones index gaining around 250 points on Thursday.
Via
Benzinga
Topics
Stocks
Ocugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical Officer
March 18, 2024
From
Ocugen
Via
GlobeNewswire
Ocugen, Inc. Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410
March 13, 2024
From
Ocugen
Via
GlobeNewswire
Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street
↗
March 07, 2024
Could these biotech companies still win in the vaccine market and beyond?
Via
The Motley Fool
Ocugen to Present at Investing in Cures Summit
March 06, 2024
From
Ocugen
Via
GlobeNewswire
Medical Breakthrough Stocks Under $1: OCGN, VERO, RSCI, VTAK, ENVB
February 28, 2024
Via
AB Newswire
Topics
Intellectual Property
Ocugen Clinical Showcase Webcast Now Available
February 28, 2024
From
Ocugen
Via
GlobeNewswire
Meme Stock Meltdowns: 3 Names to Sell Before They Crash
↗
February 26, 2024
These once-popular meme stocks are now in free-fall, highlighting the urgent need to offload them from your portfolios.
Via
InvestorPlace
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
February 26, 2024
Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
February 26, 2024
We're starting the trading week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!
Via
InvestorPlace
Ocugen, Inc. Announces Dosing Completion of Subjects with Stargardt in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410ST
February 22, 2024
From
Ocugen
Via
GlobeNewswire
Ocugen to Present at 2024 BIO CEO & Investor Conference
February 21, 2024
From
Ocugen
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
February 21, 2024
Via
Benzinga
Healthcare Innovations and Collaborations Fuel Industry Expansion Stocks Under $1 Look Now! OCGN, VTAK, RSCI, VERU, AGEN
February 20, 2024
Via
AB Newswire
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
February 20, 2024
Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.
Via
Benzinga
Dear OCGN Stock Fans, Mark Your Calendars for Feb. 21
↗
February 20, 2024
Ocugen stock is rising higher on Tuesday as OCGN fans prepare for a Clinical Showcase tomorrow that could be a positive catalyst for shares.
Via
InvestorPlace
Why Discover Financial Services Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
↗
February 20, 2024
Shares of Discover Financial Services (NYSE: DFS) shares rose sharply in today’s pre-market trading.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
February 20, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
February 20, 2024
Pre-market stock movers are a hot topic on Tuesday morning as we start the day with a breakdown of all the latest stock market news!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
↗
February 16, 2024
Via
Benzinga
Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024
February 14, 2024
From
Ocugen
Via
GlobeNewswire
Ocugen to Present at Pharma Market Research Conference
January 31, 2024
From
Ocugen
Via
GlobeNewswire
Ocugen, Inc. Announces Bob Smith Joins Business Advisory Board
January 16, 2024
From
Ocugen
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
January 02, 2024
Via
Benzinga
Ocugen Gains FDA Alignment on Key Aspects of OCU400—Modifier Gene Therapy—Pivotal Phase 3 Study Design
December 21, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen Announces OCU400 Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Retinitis Pigmentosa Associated with RHO Mutations
December 19, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410—Modifier Gene Therapy—for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
December 13, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen CEO to Present at NobleCon19 – Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
November 29, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410ST—Modifier Gene Therapy—for Stargardt Disease
November 10, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen (OCGN) Q3 2023 Earnings Call Transcript
↗
November 09, 2023
OCGN earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
35
36
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today